Global Left Atrial Appendage Closure Market 2017-2021

左心耳閉鎖術の世界市場2017-2021

◆タイトル:Global Left Atrial Appendage Closure Market 2017-2021
◆商品コード:IRTNTR11341
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年1月2日
◆ページ数:115
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥495,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、左心耳閉鎖術の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、左心耳閉鎖術の世界市場規模及び予測、製品別分析、需要先別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Left Atrial Appendage Closure
Atrial fibrillation is one of the most common types of arrhythmia and is characterized by fast and irregular heart rhythms. The atria of patients suffering from the disease do not function properly. Atrial fibrillation can cause chest pain, heart failure, or stroke. The doctor needs to identify the first detected event of atrial fibrillation in a patient. The occurrence of two or more events of atrial fibrillation results in it being considered recurrent. In paroxysmal atrial fibrillation, the arrhythmia ends spontaneously, whereas in persistent atrial fibrillation the arrhythmia continues for more than a week.

Technavio’s analysts forecast the global left atrial appendage closure market to grow at a CAGR of 33.54% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global left atrial appendage closure market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sale of medical devices required for left atrial appendage closure.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Left Atrial Appendage Closure Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• AtriCure
• Boston Scientific
• Coherex Medical
• St. Jude Medical

[Other prominent vendors]
• Occlutech
• Lifetech Scientific
• SentreHEART

[Market driver]
• Increasing incidences of atrial fibrillation
• For a full, detailed list, view our report

[Market challenge]
• Increasing product recalls hindering growth prospects
• For a full, detailed list, view our report

[Market trend]
• Emergence of 3D printing technology
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights
• Atrial fibrillation
• LAA closure devices

PART 05: Market landscape
• Market overview
• Five forces analysis

PART 06: Pipeline analysis

PART 07: Clinical trials

PART 08: Regulation of LAA closure devices

PART 09: Market segmentation by product type
• Epicardial LAA closure device
• Endocardial LAA closure device

PART 10: Market segmentation by end-user
• Hospitals
• ASCs
• Heart clinics

PART 11: Geographical segmentation
• LAA closure market in Americas
• LAA closure market in EMEA
• LAA closure market in APAC

PART 12: Market drivers
• Increasing incidences of atrial fibrillation
• Growing product approvals fueling market growth
• Potential long-term cost-effectiveness associated with use of LAA closure devices
• Shift from open to MI surgeries

PART 13: Impact of drivers

PART 14: Market challenges
• Increasing product recalls hindering growth prospects
• High acceptance of warfarin and dabigatran
• Stringent regulatory environment affecting product approvals
• Complications associated with LAA closure procedures

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Emergence of 3D printing technology
• Emergence of hybrid approach in LAA closure techniques
• Growing focus on clinical trials
• Rising inorganic growth strategies

PART 17: Vendor landscape
• Competitive scenario
• Key news
• M&A

PART 18: Key vendor analysis
• AtriCure
• Boston Scientific
• Coherex Medical2
• St. Jude Medical6
• Other prominent vendors2

PART 19: Appendix3
• List of abbreviations3

PART 20: Explore Technavio4

[List of Exhibits]

Exhibit 01: Snapshot of LAA closure market in 2016
Exhibit 02: Factors affecting LAA closure market
Exhibit 03: Snapshot of global LAA closure market
Exhibit 04: Timeline chart representing the approvals for LAA closure devices
Exhibit 05: Factors driving demand for LAA closure devices
Exhibit 06: Global LAA closure market 2016-2021 ($ millions)
Exhibit 07: Opportunity analysis of global LAA closure market
Exhibit 08: Five forces analysis
Exhibit 09: Snapshot of regulation of medical devices
Exhibit 10: Timeline of key events – WATCHMAN device regulations
Exhibit 11: Global LAA closure devices market segmentation by product type
Exhibit 12: Global LAA closure market segmentation by product type 2016 and 2021 (%)
Exhibit 13: Lifecycle analysis of global LAA closure market by product type
Exhibit 14: Global LAA closure market segmentation by product type 2016: Lifecycle analysis
Exhibit 15: Epicardial and endocardial LAA closure classification
Exhibit 16: Global LAA closure market segmentation by product type analysis
Exhibit 17: Highlights of endocardial LAA closure market
Exhibit 18: Global epicardial LAA closure market 2016-2021 ($ millions)
Exhibit 19: Highlights of endocardial LAA closure market
Exhibit 20: Global endocardial LAA closure market 2016-2021 ($ millions)
Exhibit 21: Global LAA closure market segmentation by product type 2016-2021 ($ millions)
Exhibit 22: Global LAA closure market segmentation by product type 2016-2021 (%)
Exhibit 23: Global LAA closure market segmentation by end-user 2016
Exhibit 24: Global LAA closure market segmentation by geography 2016 and 2021 (%)
Exhibit 25: Global LAA closure market segmentation by geography 2016: Analysis
Exhibit 26: Market growth lifecycle analysis of global LAA closure devices by geography
Exhibit 27: Market overview: Americas
Exhibit 28: LAA closure devices approvals until 2016 in Americas
Exhibit 29: LAA closure market in Americas 2016-2021 ($ millions)
Exhibit 30: Market overview: EMEA
Exhibit 31: LAA closure market in EMEA 2016-2021 ($ millions)
Exhibit 32: Product approvals in EMEA until 2016
Exhibit 33: Market overview: APAC
Exhibit 34: LAA closure market in APAC 2016-2021 ($ millions)
Exhibit 35: Global LAA closure market segmentation by geography 2016-2021 ($ millions)
Exhibit 36: Global LAA closure market segmentation by geography 2016-2021 (%)
Exhibit 37: Incidences of atrial fibrillation
Exhibit 38: Key product approvals
Exhibit 39: Key takeaways associated with cost-effectiveness of LAA closure devices
Exhibit 40: Key factors fueling the adoption rates of LAA closure devices
Exhibit 41: Impact of drivers
Exhibit 42: Major product recalls
Exhibit 43: Key factors fueling the adoption of warfarin and dabigatran
Exhibit 44: Key factors hindering the product approvals
Exhibit 45: Complications involved in LAA closure devices
Exhibit 46: Impact of drivers and challenges
Exhibit 47: Key factors that will have a positive impact on the market growth
Exhibit 48: Emergence of hybrid approach in LAA closure
Exhibit 49: Ongoing clinical trials of LAA closure device
Exhibit 50: M&A
Exhibit 51: Market share analysis of vendors in LAA closure market 2016
Exhibit 52: Competitive structure analysis of global LAA closure market 2016
Exhibit 53: Market penetration of various manufacturers of global LAA closure market 2016
Exhibit 54: Strategic success factors of companies in global LAA closure market
Exhibit 55: Key highlights of AtriCure
Exhibit 56: AtriCure strength assessment
Exhibit 57: AtriCure strategy assessment
Exhibit 58: AtriCure: Opportunity assessment
Exhibit 59: Key highlights of Boston Scientific
Exhibit 60: Boston Scientific: Strength assessment
Exhibit 61: Boston Scientific: Strategy assessment
Exhibit 62: Boston Scientific: Opportunity assessment
Exhibit 63: Key highlights of Coherex Medical
Exhibit 64: Coherex Medical: Strength assessment
Exhibit 65: Coherex Medical: Strategy assessment
Exhibit 66: Coherex Medical: Opportunity assessment
Exhibit 67: Key highlights of St. Jude Medical
Exhibit 68: St. Jude Medical: Strength assessment
Exhibit 69: St. Jude Medical: Strategy assessment
Exhibit 70: St. Jude Medical: Opportunity assessment



【掲載企業】

AtriCure, Boston Scientific, Coherex Medical, St. Jude Medical, Occlutech, Lifetech Scientific, SentreHEART.

【資料のキーワード】

左心耳閉鎖術、左心耳(LAA)、左心耳閉鎖術装置、心房細動、医療機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[左心耳閉鎖術の世界市場2017-2021] (Global Left Atrial Appendage Closure Market 2017-2021 / IRTNTR11341)販売に関する免責事項
[左心耳閉鎖術の世界市場2017-2021] (Global Left Atrial Appendage Closure Market 2017-2021 / IRTNTR11341)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆